Posts

Showing posts with the label infection

Otezla Upper Respiratory Infection

Image
Diarrhea nausea and upper respiratory tract infection were the most commonly reported adverse reactions. Otezlaapremilast is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Review The Safety Data Of Otezla Apremilast In The Treatment Of Plaque Psoriasis Otezla Healthcare Professional Site Adverse reactions reported in at least 2 of patients taking Otezla that occurred at a frequency at least 1 higher than that observed in patients taking placebo for up to 16 weeks after the initial 5-day titration were Otezla placebo. Otezla upper respiratory infection . After 2 weeks of treatment most patients who had symptoms of diarrhea and nausea no longer felt the symptoms without stopping treatment. Upper respiratory tract infection 39 18. Side effects of Otezla include diarrhea nausea vomiting upper respiratory tract infection runny nose sneezing or congestion abdominal pain tension headache and h